Literature DB >> 15270640

Trial watch: Xenova's TA-NIC vaccine shows promise.

.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15270640     DOI： 10.1586/14760584.3.4.386

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  3 in total

Review 1.  New directions in nicotine vaccine design and use.

Authors:  Paul R Pentel; Mark G LeSage
Journal:  Adv Pharmacol       Date:  2014

Review 2.  Targeting nicotine addiction: the possibility of a therapeutic vaccine.

Authors:  José Juan Escobar-Chávez; Clara Luisa Domínguez-Delgado; Isabel Marlen Rodríguez-Cruz
Journal:  Drug Des Devel Ther       Date:  2011-04-18       Impact factor: 4.162

Review 3.  Nicotine vaccines to assist with smoking cessation: current status of research.

Authors:  Tobias Raupach; Philippe H J Hoogsteder; Constant P Onno van Schayck
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.